OSCR

5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity.

Overview

Authors: Kyu-Seok Hwang1, Se Hwan Ahn2, Yuji Son1, Seong Soon Kim1, Dae-Seop Shin1, Jung Yoon Yang1, Chong Hak Chae1, Michiko Nakamura3,4, Il-Sung Jang3,4, Gahyeon Kim1,5, Dong Gun Kim2, Pyeongkeun Kim2, Yerim Heo2, Sunjae Bae2, Hohjai Lee2, Jin Hee Ahn2,6, Myung Ae Bae1,5
  1. Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea; (K.-S.H.); (Y.S.); (S.S.K.); (D.-S.S.); (J.Y.Y.); (C.H.C.); (G.K.)
  2. Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea; (S.H.A.); (D.G.K.); (P.K.); (Y.H.); (S.B.)
  3. Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu 41940, Republic of Korea; (M.N.); (I.-S.J.)
  4. Brain Science & Engineering Institute, Kyungpook National University, Daegu 41940, Republic of Korea
  5. Department of Medical Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, Republic of Korea
  6. JD Bioscience Inc., 208 Cheomdan-dwagiro, Buk-gu, Gwangju 61011, Republic of Korea
Journal: Molecules (Basel, Switzerland), volume 31, issue 9, article 1511
Dates: received 30 March 2026; accepted 28 April 2026; published online 1 May 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/molecules31091511 · PMID 42123875 · PMCID PMC13164629 · OpenAlex W7160207336
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: human (organism), zebrafish (organism), epilepsy (population)
Methods: Statistics
Keywords: Dravet syndrome, treatment, monoamine oxidase, SCN1A, zebrafish
MeSH: Epilepsies, Myoclonic*, Monoamine Oxidase*, Monoamine Oxidase Inhibitors*, Oxadiazoles*, Animals, Disease Models, Animal, Hippocampus, Humans, Molecular Docking Simulation, NAV1.1 Voltage-Gated Sodium Channel, Zebrafish (* major topic)
Topic: Epilepsy research and treatment (Psychiatry and Mental health, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 46 references in the paper

Abstract

Dravet syndrome (DS) is a severe, catastrophic childhood epilepsy predominantly caused by loss-of-function mutations in the SCN1A gene, which encodes the voltage-gated sodium channel Nav1.1. In this study, we evaluated the therapeutic potential of 5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663), a novel small molecule designed to address the complex pathophysiology of DS. Using scn1lab knockout (KO) zebrafish larvae—a robust vertebrate model for DS—we demonstrated that GM-90663 significantly alleviates seizure-like behavioral movements and rescues deficit in cognitive-like functions. Whole-cell patch-clamp recordings in hippocampal slices revealed that GM-90663 modulates voltage-gated Na+ channel kinetics; specifically, it suppresses slow ramp-induced currents, thereby effectively attenuating neuronal hyperexcitability. Furthermore, neurochemical profiling indicated that GM-90663 treatment leads to a marked increase in endogenous serotonin (5-HT) levels in both wild-type and KO larvae. Molecular docking simulations and subsequent in vitro enzymatic assays confirmed that this elevation in serotonin is mediated through the potent inhibition of monoamine oxidase (MAO) activity. Collectively, our findings suggest that GM-90663 exerts its anti-seizure effects through a synergistic dual mechanism—stabilizing sodium channel conductance and elevating serotonergic activity—positioning it as a promising multi-target candidate for the treatment of DS.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding authors.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Funding: added National Research Foundation: RS-2024-00411137; Ministry of Trade, Industry and Energy: RS-2024-00449703; Korea Research Institute of Chemical Technology: KK2631-20; National Research Foundation of Korea: RS‐2024‐00411137, RS-2024-00348338; National Research Council of Science and Technology: KK2631-20, RS-2024-00411137; Ministry of Science and ICT, South Korea: RS-2024-00348338, RS-2024-00411137

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 17 authors, 5 keywords, 11 MeSH terms, 44 references.

Cite

This paper

Hwang, K.-S., Ahn, S. H., Son, Y., Kim, S. S., Shin, D.-S., Yang, J. Y., Chae, C. H., Nakamura, M., Jang, I.-S., Kim, G., Kim, D. G., Kim, P., Heo, Y., Bae, S., Lee, H., Ahn, J. H., & Bae, M. A. (2026). 5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity. Molecules (Basel, Switzerland), 31(9), 1511. https://doi.org/10.3390/molecules31091511

BibTeX

@article{hwang20265,
author = {Hwang, Kyu-Seok and Ahn, Se Hwan and Son, Yuji and Kim, Seong Soon and Shin, Dae-Seop and Yang, Jung Yoon and Chae, Chong Hak and Nakamura, Michiko and Jang, Il-Sung and Kim, Gahyeon and Kim, Dong Gun and Kim, Pyeongkeun and Heo, Yerim and Bae, Sunjae and Lee, Hohjai and Ahn, Jin Hee and Bae, Myung Ae},
title = {{5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity}},
journal = {Molecules (Basel, Switzerland)},
year = {2026},
month = may,
volume = {31},
number = {9},
pages = {1511},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {1420-3049},
doi = {10.3390/molecules31091511},
url = {https://doi.org/10.3390/molecules31091511},
pmid = {42123875},
pmcid = {PMC13164629}
}

RIS

TY - JOUR
AU - Hwang, Kyu-Seok
AU - Ahn, Se Hwan
AU - Son, Yuji
AU - Kim, Seong Soon
AU - Shin, Dae-Seop
AU - Yang, Jung Yoon
AU - Chae, Chong Hak
AU - Nakamura, Michiko
AU - Jang, Il-Sung
AU - Kim, Gahyeon
AU - Kim, Dong Gun
AU - Kim, Pyeongkeun
AU - Heo, Yerim
AU - Bae, Sunjae
AU - Lee, Hohjai
AU - Ahn, Jin Hee
AU - Bae, Myung Ae
TI - 5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity
T2 - Molecules (Basel, Switzerland)
J2 - Molecules
PY - 2026
DA - 2026/05/01
VL - 31
IS - 9
SP - 1511
SN - 1420-3049
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/molecules31091511
UR - https://doi.org/10.3390/molecules31091511
LA - en
ER -

CSL-JSON

{
"id": "10.3390/molecules31091511",
"type": "article-journal",
"title": "5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity",
"container-title": "Molecules (Basel, Switzerland)",
"author": [
{
"family": "Hwang",
"given": "Kyu-Seok"
},
{
"family": "Ahn",
"given": "Se Hwan"
},
{
"family": "Son",
"given": "Yuji"
},
{
"family": "Kim",
"given": "Seong Soon"
},
{
"family": "Shin",
"given": "Dae-Seop"
},
{
"family": "Yang",
"given": "Jung Yoon"
},
{
"family": "Chae",
"given": "Chong Hak"
},
{
"family": "Nakamura",
"given": "Michiko"
},
{
"family": "Jang",
"given": "Il-Sung"
},
{
"family": "Kim",
"given": "Gahyeon"
},
{
"family": "Kim",
"given": "Dong Gun"
},
{
"family": "Kim",
"given": "Pyeongkeun"
},
{
"family": "Heo",
"given": "Yerim"
},
{
"family": "Bae",
"given": "Sunjae"
},
{
"family": "Lee",
"given": "Hohjai"
},
{
"family": "Ahn",
"given": "Jin Hee"
},
{
"family": "Bae",
"given": "Myung Ae"
}
],
"container-title-short": "Molecules",
"volume": "31",
"issue": "9",
"page": "1511",
"DOI": "10.3390/molecules31091511",
"PMID": "42123875",
"PMCID": "PMC13164629",
"ISSN": "1420-3049",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/molecules31091511",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1093/braincomms/fcag323 [code]
Induced epileptic seizures in larval zebrafish reveal a synaptic modulation associated with the post-ictal state.
Journal: Brain communications
In common: zebrafish, epilepsy, 3 references
[2] doi:10.1038/s41467-026-71371-6
Molecular and functional dissection using CaMPARI-seq reveals the neuronal organization for dissociating optic flow-dependent behaviors.
Journal: Nature communications
In common: zebrafish, 2 references
[3] doi:10.3389/fneur.2026.1793970 [code]
The cumulative impact of seizures: the science underlying how seizures beget seizures.
Journal: Frontiers in neurology
In common: epilepsy, 2 references
[4] doi:10.1021/ehp.6c00394 [code]
Multibehavioral Phenotyping in Early-Life-Stage Zebrafish for Identifying Disruptors of Nonassociative Learning.
Journal: Environmental health perspectives
In common: zebrafish, 1 reference
[5] doi:10.1016/j.isci.2026.117207
Physical activity stimulates neurogenesis via sensory neuron activity in postembryonic zebrafish.
Journal: iScience
In common: zebrafish, 1 reference
[6] doi:10.7554/elife.110370 [code]
Serotonergic modulation of motor subspace dynamics drives a sleep-independent quiescent state.
Journal: eLife
In common: zebrafish, 1 reference
[7] doi:10.1038/s41467-026-75490-y [code]
Topographically organized dorsal raphe activity modulates forebrain sensory-motor representations and contributes to defensive behaviors.
Journal: Nature communications
In common: zebrafish, 1 reference
[8] doi:10.1038/s41467-026-72222-0 [code]
Eye movement kinematics reveal novel circadian organization of sleep substates.
Journal: Nature communications
In common: zebrafish, 1 reference
[9] doi:10.1096/fj.202504890rr
Purinergic Receptor P2Y2 Regulates Neurogenesis and Functional Recovery Following Spinal Cord Injury in Zebrafish.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology
In common: zebrafish, 1 reference
[10] doi:10.1016/j.stemcr.2026.102966
Optimized chemogenetic ablation and regeneration of enteric nervous system neurons in zebrafish.
Journal: Stem cell reports
In common: zebrafish, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.